-+ 0.00%
-+ 0.00%
-+ 0.00%

Universe Pharmaceuticals to buy Best Praise for US$10.75 million in stock

PUBT·06/26/2026 20:05:19
Listen to the news
Universe Pharmaceuticals to buy Best Praise for US$10.75 million in stock
  • Universe Pharmaceuticals agreed to buy Best Praise International, which holds five China patents with potential pharmaceutical applications.
  • Purchase price set at USD 10.75 million, paid with 4,376,552 Class A ordinary shares.
  • Patents span elderly healthcare-related areas, including age-related diseases, cognitive and cardiovascular applications, plus antibacterial compounds and drug-delivery technologies.
  • Deal is expected to close in the third quarter of 2026, subject to customary closing conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Universe Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606261605PRIMZONEFULLFEED9753039) on June 26, 2026, and is solely responsible for the information contained therein.